PetVivo Holdings has successfully raised $1.5 million through preferred stock offerings. Future revenue expectations include a growth of $1.5 million in the fiscal fourth quarter of 2025. Strategic measures to increase adoption of the Spring product involve participation in veterinary conferences and collaborations.